Abstract
Nocturnal enuresis affects one in ten children at school start and lingers until adulthood in approximately one percent of the population. The condition is often inherited, and the pathogenesis is usually a combination of nocturnal polyuria, nocturnal detrusor overactivity, and/or high arousal thresholds. Enuresis adversely affects quality of life and self-esteem. The vast majority of enuretic children can, and should, be managed without blood tests, radiology, or invasive urodynamics. With a proper case history, the small minority of children who need extensive evaluation can easily be found. Constipation and/or daytime incontinence, if present, should be managed before the enuresis is addressed. Active treatment is indicated from approximately the age of six and involves an enuresis alarm and/or desmopressin medication. The alarm is a conditioning device which demands a high degree of motivation from the child and family but has a high chance of curing the child. Desmopressin acts antidiuretically, is given in the evening, and is effective mainly in enuretic children who have nocturnal polyuria. The drug is safe to give as long as it is not combined with excessive fluid intake. Second-line therapies include anticholinergics and tricyclic antidepressant treatment. Anticholinergics carry a risk for constipation or the accumulation of residual urine. Tricyclic antidepressants are severely cardiotoxic if overdosed.
Similar content being viewed by others
References
Austin PF, Ferguson G, Yan Y, Campigotto MJ, Royer ME, Coplen DE. Combination therapy with desmopressin and an anticholinergic medication for nonresponders to desmopressin for monosymptomatic nocturnal enuresis: randomized, double-blind, placebo-controlled trial. Pediatrics. 2008;122(5):1027–32.
Austin P, Bauer S, Bower W, Chase J, Franco I, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children’s Continence Society. J Urol. 2014; 191(6):1863–5.
Baeyens D, Lierman A, Roeyers H, Hoebeke P, Vande WJ. Adherence in children with nocturnal enuresis. J Pediatr Urol. 2009;5:105–9.
Bakwin H. The genetics of enuresis. Clin Dev Med. 1973;48/49:73–7.
Borgström M, Bergsten A, Tunebjer M, Hedin Skogman B, Nevéus T. Daytime urotherapy in nocturnal enuresis: a randomised, controlled trial. Arch Dis Child. 2022;107(6):570–4. https://doi.org/10.1136/archdischild-2021-323488. Epub 2022 Jan 24. PMID: 35074830.
Chandra M, Saharia R, Hill V, Shi Q. Prevalence of diurnal voiding symptoms and difficult arousal from sleep in children with nocturnal enuresis. J Urol. 2004;172(1):311–6.
Charalampous S, Printza N, Hashim H, Bantouraki M, Rompis V, Ioannidis E, et al. Bladder wall thickness and urodynamic correlation in children with primary nocturnal enuresis. J Pediatr Urol. 2013;9(3):334–8.
De Guchtenaere A, Vande Walle C, Van Sintjan P, Donckerwolcke R, Raes A, Dehoorne J, et al. Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning. J Urol. 2007;178(6):2635–9.
Dhondt K, Baert E, Van Herzeele C, Raes A, Groen LA, Hoebeke P, et al. Sleep fragmentation and increased periodic limb movements are more common in children with nocturnal enuresis. Acta Paediatr. 2014;103(6):e268–72.
Foldspang A, Mommsen S. Adult female urinary incontinence and childhood bedwetting. J Urol. 1994;152(1):85–8.
Fonseca EG, Bordallo AP, Garcia PK, Munhoz C, Silva CP. Lower urinary tract symptoms in enuretic and nonenuretic children. J Urol. 2009;182:1978–83.
Forsythe WI, Redmond A. Enuresis and spontaneous cure rate: study of 1129 enuretics. Arch Dis Child. 1974;49:259–63.
Gepertz S, Nevéus T. Imipramine for therapy resistant enuresis: a retrospective evaluation. J Urol. 2004;171(6 Pt 2):2607–10.
Gish P, Mosholder AD, Truffa M, Johann-Liang R. Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases. J Pediatr. 2009;155(3):432–4.
Glazener CM, Evans JH. Tricyclic and related drugs for nocturnal enuresis in children. Cochrane Database Syst Rev. 2000;2:CD002117.
Glazener CM, Evans JH. Desmopressin for nocturnal enuresis. Cochrane Database Syst Rev. 2002;3:CD002112.
Hägglöf B, Andrén O, Bergström E, Marklund L, Wendelius M. Self-esteem before and after treatment in children with nocturnal enuresis and urinary incontinence. Scand J Urol Nephrol. 1997;31(Suppl 183):79–82.
Hansson S, Hjälmås K, Jodal U, Sixt R. Lower urinary tract dysfunction in girls with untreated asymptomatic or covert bacteriuria. J Urol. 1990;143:333–5.
Hirasing RA, van Leerdam FJ, Bolk-Bennink L, Janknegt RA. Enuresis nocturna in adults. Scand J Urol Nephrol. 1997;31(6):533–6.
Hoebeke P, Bower W, Combs A, de Jong TP, Yang S. Diagnostic evaluation of children with daytime incontinence. J Urol. 2010;183:693–703.
Joensson IM, Siggaard C, Rittig S, Hagstroem S, Djurhuus JC. Transabdominal ultrasound of rectum as a diagnostic tool in childhood constipation. J Urol. 2008;179(5):1997–2002.
Kamperis K. Nocturnal enuresis in children: The role of arginine-vasopressin. Handb Clin Neurol. 2021;181:289–97. https://doi.org/10.1016/B978-0-12-820683-6.00021-X. PMID: 34238464.
Kamperis K, Rittig S, Schaumburg HL, Hansen MN, Djurhuus JC. Predictors of response to dDAVP in monosymptomatic nocturnal enuresis. The role of bladder capacity (abstract). Pediatr Nephrol. 2001;16(Suppl):C109.
Kamperis K, Hagstroem S, Rittig S, Djurhuus JC. Combination of the enuresis alarm and desmopressin. Second line treatment for enuresis nocturna. J Urol. 2008;179(3):1128–31.
Kamperis K, Rittig S, Bower WF, Djurhuus JC. Effect of indomethacin on desmopressin resistant nocturnal polyuria and nocturnal enuresis. J Urol. 2012;188(5):1915–22.
Kushnir J, Cohen-Zrubavel V, Kushnir B. Night diapers use and sleep in children with enuresis. Sleep Med. 2013;14:1013–6.
Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics. 1997;100:228–32.
Lundmark E, Nevéus T. Reboxetine as a treatment for refractory enuresis; a pilot study. Scand J Urol Nephrol. 2009;43(5):365–8.
Mehlenbeck R, Spirito A, Owens J, Boergers J. The clinical presentation of childhood partial arousal parasomnias. Sleep Med. 2000;2000(1):307–12.
Nevéus T. The role of sleep and arousal in nocturnal enuresis. Acta Paediatr. 2003;92(10):1118–23.
Nevéus T. The evaluation and treatment of therapy-resistant enuresis: a review. Upsala J Med Sci. 2006;111(1):61–72.
Nevéus T. Pathogenesis of enuresis: towards a new understanding. Int J Urol. 2017;24(3):174–82. https://doi.org/10.1111/iju.13310. Epub 2017 Feb 16. PMID: 28208214.
Nevéus T, Tuvemo T, Läckgren G, Stenberg A. Bladder capacity and renal concentrating ability in enuresis – pathogenic implications. J Urol. 2001;165(6 pt 1):2022–5.
Nevéus T, Eggert P, Evans J, Macedo A, Rittig S, Tekgül S, et al. Evaluation and treatment of monosymptomatic enuresis – a standardisation document from the International Children’s Continence Society (ICCS). J Urol. 2010;183:441–7.
Nevéus T, Leissner L, Rudblad S, Bazargani F. Orthodontic widening of the palate may provide a cure for selected children with therapy-resistant enuresis. Acta Paediatrica. 2014;103(11):1187–91.
Nevéus T, Fonseca E, Franco I, Kawauchi A, Kovacevic L, Nieuwhof-Leppink A, Raes A, Tekgül S, Yang SS, Rittig S. Management and treatment of nocturnal enuresis-an updated standardization document from the International Children’s Continence Society. J Pediatr Urol. 2020;16(1):10–9. https://doi.org/10.1016/j.jpurol.2019.12.020. Epub 2020 Jan 30. PMID: 32278657.
Nieuwhof-Leppink AJ, Hussong J, Chase J, Larsson J, Renson C, Hoebeke P, Yang S, von Gontard A. Definitions, indications and practice of urotherapy in children and adolescents: a standardization document of the International Children’s Continence Society (ICCS). J Pediatr Urol. 2021;17(2):172–81. https://doi.org/10.1016/j.jpurol.2020.11.006. Epub 2020 Nov 5. PMID: 33478902.
Perrin N, Sayer L, While A. The efficacy of alarm therapy versus desmopressin therapy in the treatment of primary mono-symptomatic nocturnal enuresis: a systematic review. Prim Health Care Res Dev. 2015;16(1):21–31.
Radvanska E, Kamperis K, Kleif A, Kovács L, Rittig S. Effect of laser acupuncture for monosymptomatic nocturnal enuresis on bladder reservoir function and nocturnal urine output. J Urol. 2011;185(5).
Rasmussen PV, Kirk J, Rittig S, Djurhuus JC. The enuretic episode - a complete micturition from a bladder with normal capacity? A critical reappraisal of the definition. Scand J Urol Nephrol. 1997;31(Suppl 183):23–4.
Rittig S, Knudsen UB, Nørgaard JP, Pedersen EB, Djurhuus JC. Abnormal diurnal rhythm of plasma Vasopressin and urinary output in patients with enuresis. Am J Phys. 1989;256:F664–71.
Robson WL, Nørgaard JP, Leung AK. Hyponatremia in patients with nocturnal enuresis treated with DDAVP. Eur J Pediatr. 1996;155(11):959–62.
Robson WL, Leung AK, Nørgaard JP. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis. J Urol. 2007;178(1):24–30.
Seabrook JA, Gorodzinsky F, Freedman S. Treatment of primary nocturnal enuresis: a randomized clinical trial comparing hypnotherapy and alarm therapy. Paediatr Child Health. 2005;10(10):609–10.
Shopfner CE. Urinary tract pathology associated with constipation. Radiology. 1968;90:865–77.
Söderström U, Hoelcke M, Alenius L, Söderling A-C, Hjern A. Urinary and faecal incontinence: a population-based study. Acta Paediatr. 2004;93:386–9.
Tingelstad JB. The cardiotoxicity of the tricyclics. J Am Acad Child Adolesc Psychiatry. 1991;30:1991.
Van Arendonk KJ, Austin JC, Boyt MA, Cooper CS. Frequency of wetting is predictive of response to anticholinergic treatment in children with overactive bladder. Urology. 2006;67(5):1049–54.
Vande Walle J, Rittig S, Bauer S, Eggert P, Marschall-Kehrel D, Tekgül S. Practical consensus guidelines for the management of enuresis. Eur J Pediatr. 2012;171:971–83.
von Gontard A, Eiberg H, Hollmann E, Rittig S, Lehmkuhl G. Molecular genetics of nocturnal enuresis: clinical and genetic heterogeneity. Acta Paediatr. 1998;87(5):571–8.
von Gontard A, Baeyens D, Van Hoecke E, Warzak WJ, Bachmann C. Psychological and psychiatric issues in urinary and fecal incontinence. J Urol. 2011;185(6):2303–7.
Weider DJ, Sateia MJ, West RP. Nocturnal enuresis in children with upper airway obstruction. Otolaryngol Head Neck Surg. 1991;105(3):427–32.
Wolfish NM, Pivik RT, Busby KA. Elevated sleep arousal thresholds in enuretic boys: clinical implications. Acta Paediatr. 1997;86:381–4.
Yeung CK, Chiu HN, Sit FK. Bladder dysfunction in children with refractory monosymptomatic primary nocturnal enuresis. J Urol. 1999;162:1049–55.
Yeung CK, Sreedhar B, Sihoe JD, Sit FK, Lau J. Differences in characteristics of nocturnal enuresis between children and adolescents: a critical appraisal from a large epidemiological study. BJU Int. 2006;97(5):1069–73.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer-Verlag GmbH Germany, part of Springer Nature
About this entry
Cite this entry
Nevéus, T. (2022). Nocturnal Enuresis. In: Puri, P. (eds) Pediatric Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38482-0_182-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-38482-0_182-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-38482-0
Online ISBN: 978-3-642-38482-0
eBook Packages: Springer Reference MedicineReference Module Medicine